Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Author response: Unintended consequences of Mayo paraneoplastic evaluations.

Callaghan BC, Burke JF.

Neurology. 2019 Sep 24;93(13):606-607. doi: 10.1212/WNL.0000000000008180. No abstract available.

PMID:
31551275
2.

Author response: Unintended consequences of Mayo paraneoplastic evaluations.

Callaghan BC.

Neurology. 2019 Sep 24;93(13):604. doi: 10.1212/WNL.0000000000008177. No abstract available.

PMID:
31551273
3.

Quantitation and chemical coding of enteroendocrine cell populations in the human jejunum.

Fazio Coles TE, Fothergill LJ, Hunne B, Nikfarjam M, Testro A, Callaghan B, McQuade RM, Furness JB.

Cell Tissue Res. 2019 Sep 2. doi: 10.1007/s00441-019-03099-3. [Epub ahead of print]

PMID:
31478137
4.

Bilateral nerve conduction studies in the evaluation of distal symmetric polyneuropathy.

Dupuis JE, Li J, Callaghan BC, Reynolds EL, London ZN.

Muscle Nerve. 2019 Sep;60(3):305-307. doi: 10.1002/mus.26616. Epub 2019 Jul 2.

PMID:
31228276
5.

Diabetic neuropathy.

Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V.

Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1. Review.

PMID:
31197153
6.

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.

Tang Y, Lenzini PA, Pop-Busui R, Ray PR, Campbell H, Perkins BA, Callaghan B, Wagner MJ, Motsinger-Reif AA, Buse JB, Price TJ, Mychaleckyj JC, Cresci S, Shah H, Doria A.

Diabetes. 2019 Aug;68(8):1649-1662. doi: 10.2337/db19-0109. Epub 2019 May 24.

PMID:
31127053
7.

Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD-10 hospital diagnoses and drug prescriptions?

Christensen DH, Knudsen ST, Nicolaisen SK, Andersen H, Callaghan BC, Finnerup NB, Jensen TS, Thomsen RW.

Clin Epidemiol. 2019 May 1;11:311-321. doi: 10.2147/CLEP.S197474. eCollection 2019.

8.

The brain-gut connection: environmental influences on gastrointestinal biology and neurobehavior across development.

Firestein M, Callaghan B.

Dev Psychobiol. 2019 Jul;61(5):639. doi: 10.1002/dev.21869. Epub 2019 May 21. No abstract available.

PMID:
31115036
9.

Out-of-pocket costs are on the rise for commonly prescribed neurologic medications.

Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Magliocco B, Esper GJ, Burke JF.

Neurology. 2019 May 28;92(22):e2604-e2613. doi: 10.1212/WNL.0000000000007564. Epub 2019 May 1. Erratum in: Neurology. 2019 Oct 8;93(15):688.

PMID:
31043472
10.

Decreased Amygdala Reactivity to Parent Cues Protects Against Anxiety Following Early Adversity: An Examination Across 3 Years.

Callaghan BL, Gee DG, Gabard-Durnam L, Telzer EH, Humphreys KL, Goff B, Shapiro M, Flannery J, Lumian DS, Fareri DS, Caldera C, Tottenham N.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jul;4(7):664-671. doi: 10.1016/j.bpsc.2019.02.001. Epub 2019 Feb 20.

PMID:
30952600
11.

Mind and gut: Associations between mood and gastrointestinal distress in children exposed to adversity.

Callaghan BL, Fields A, Gee DG, Gabard-Durnam L, Caldera C, Humphreys KL, Goff B, Flannery J, Telzer EH, Shapiro M, Tottenham N.

Dev Psychopathol. 2019 Mar 28:1-20. doi: 10.1017/S0954579419000087. [Epub ahead of print]

PMID:
30919798
12.

Using a Developmental Ecology Framework to Align Fear Neurobiology Across Species.

Callaghan B, Meyer H, Opendak M, Van Tieghem M, Harmon C, Li A, Lee FS, Sullivan RM, Tottenham N.

Annu Rev Clin Psychol. 2019 May 7;15:345-369. doi: 10.1146/annurev-clinpsy-050718-095727. Epub 2019 Feb 20.

PMID:
30786246
13.

Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study.

Carey MR, Callaghan BC, Kerber KA, Skolarus LE, Burke JF.

PLoS One. 2019 Feb 1;14(2):e0211599. doi: 10.1371/journal.pone.0211599. eCollection 2019.

14.

Is adolescence the missing developmental link in Microbiome-Gut-Brain axis communication?

Flannery J, Callaghan B, Sharpton T, Fisher P, Pfeifer J.

Dev Psychobiol. 2019 Jul;61(5):783-795. doi: 10.1002/dev.21821. Epub 2019 Jan 28.

PMID:
30690712
15.

Claims data analyses unable to properly characterize the value of neurologists in epilepsy care.

Hill CE, Lin CC, Burke JF, Kerber KA, Skolarus LE, Esper GJ, Magliocco B, Callaghan BC.

Neurology. 2019 Feb 26;92(9):e973-e987. doi: 10.1212/WNL.0000000000007004. Epub 2019 Jan 23.

PMID:
30674587
16.

Relationships of endocrine cells to each other and to other cell types in the human gastric fundus and corpus.

Fakhry J, Stebbing MJ, Hunne B, Bayguinov Y, Ward SM, Sasse KC, Callaghan B, McQuade RM, Furness JB.

Cell Tissue Res. 2019 Apr;376(1):37-49. doi: 10.1007/s00441-018-2957-0. Epub 2018 Nov 22.

PMID:
30467709
17.

Longitudinal pattern of pain medication utilization in peripheral neuropathy patients.

Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Burke JF.

Pain. 2019 Mar;160(3):592-599. doi: 10.1097/j.pain.0000000000001439.

PMID:
30418352
18.

Assessment of Proposed Changes to Evaluation and Management Billing Levels by Physician Specialty.

Callaghan BC, Burke JF, Skolarus LE, Kerber KA.

JAMA Neurol. 2019 Feb 1;76(2):231-232. doi: 10.1001/jamaneurol.2018.3794. No abstract available.

PMID:
30383157
19.

Unintended consequences of Mayo paraneoplastic evaluations.

Ebright MJ, Li SH, Reynolds E, Burke JF, Claytor BR, Grisold A, Banerjee M, Callaghan BC.

Neurology. 2018 Nov 27;91(22):e2057-e2066. doi: 10.1212/WNL.0000000000006577. Epub 2018 Oct 26.

PMID:
30366974
20.

Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trial.

Adams AS, Schmittdiel JA, Altschuler A, Bayliss EA, Neugebauer R, Ma L, Dyer W, Clark J, Cook B, Willyoung D, Jaffe M, Young JD, Kim E, Boggs JM, Prosser LA, Wittenberg E, Callaghan B, Shainline M, Hippler RM, Grant RW.

Diabet Med. 2019 Jan;36(1):52-61. doi: 10.1111/dme.13840. Epub 2018 Nov 7.

PMID:
30343489
21.

Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?

Rajan S, Campagnolo M, Callaghan B, Gibbons CH.

Clin Auton Res. 2019 Feb;29(1):31-39. doi: 10.1007/s10286-018-0540-0. Epub 2018 Jun 28. Review.

PMID:
29956008
22.

Reply to "Diagnosing Neuropathy in an Obese Patient": Measuring neuropathy in obese populations: Nerve conduction studies.

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Sep;129(9):2050. doi: 10.1016/j.clinph.2018.06.004. Epub 2018 Jun 14. No abstract available.

PMID:
29921550
23.

Structure-Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1.

Sadeghi M, Carstens BB, Callaghan BP, Daniel JT, Tae HS, O'Donnell T, Castro J, Brierley SM, Adams DJ, Craik DJ, Clark RJ.

ACS Chem Biol. 2018 Jun 15;13(6):1577-1587. doi: 10.1021/acschembio.8b00190. Epub 2018 May 25.

PMID:
29746088
24.

Measuring neuropathy in obese populations: Challenge accepted. Reply to "Diagnostic accuracy of neuropathy tests in obese population remains elusive".

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Jul;129(7):1504-1505. doi: 10.1016/j.clinph.2018.03.040. Epub 2018 Apr 16. No abstract available.

PMID:
29729887
25.

Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.

Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, Pop-Busui R, Feldman EL, Ji L.

Ann Clin Transl Neurol. 2018 Feb 14;5(4):397-405. doi: 10.1002/acn3.531. eCollection 2018 Apr.

26.

RADIOFREQUENCY ABLATION AND ENDOSCOPIC MUCOSAL IN TREATMENT OF EARLY NEOPLASTIC BARRETT'S OESOPHAGUS.

Callaghan B, Mainie I.

Ulster Med J. 2018 Jan;87(1):71. Epub 2018 Jan 31. No abstract available.

27.

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Ney JP, Sico JJ, Klein BC, Magliocco B, Callaghan BC, Esper GJ.

Cephalalgia. 2018 Oct;38(12):1876-1884. doi: 10.1177/0333102418762572. Epub 2018 Mar 4.

PMID:
29504480
28.

Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.

Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, Feldman EL, Callaghan BC, Charles M.

Diabetes Care. 2018 May;41(5):1068-1075. doi: 10.2337/dc17-2062. Epub 2018 Feb 27.

PMID:
29487078
29.

Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists.

Callaghan BC, Xia R, Reynolds E, Banerjee M, Burant C, Rothberg A, Pop-Busui R, Villegas-Umana E, Feldman EL.

Clin Neurophysiol. 2018 Mar;129(3):654-662. doi: 10.1016/j.clinph.2018.01.003. Epub 2018 Jan 16.

30.

The association of neurologists with headache health care utilization and costs.

Callaghan BC, Burke JF, Kerber KA, Skolarus LE, Ney JP, Magliocco B, Esper GJ.

Neurology. 2018 Feb 6;90(6):e525-e533. doi: 10.1212/WNL.0000000000004925. Epub 2018 Jan 10.

31.

Neural pathways for colorectal control, relevance to spinal cord injury and treatment: a narrative review.

Callaghan B, Furness JB, Pustovit RV.

Spinal Cord. 2018 Mar;56(3):199-205. doi: 10.1038/s41393-017-0026-2. Epub 2017 Nov 16. Review.

PMID:
29142293
32.

Amygdala Resting Connectivity Mediates Association Between Maternal Aggression and Adolescent Major Depression: A 7-Year Longitudinal Study.

Callaghan BL, Dandash O, Simmons JG, Schwartz O, Byrne ML, Sheeber L, Allen NB, Whittle S.

J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):983-991.e3. doi: 10.1016/j.jaac.2017.09.415. Epub 2017 Sep 19.

PMID:
29096781
33.

Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Fife TD, Colebatch JG, Kerber KA, Brantberg K, Strupp M, Lee H, Walker MF, Ashman E, Fletcher J, Callaghan B, Gloss DS 2nd.

Neurology. 2017 Nov 28;89(22):2288-2296. doi: 10.1212/WNL.0000000000004690. Epub 2017 Nov 1.

34.

Obesity and the nervous system: more questions - Authors' reply.

Callaghan BC, O'Brien PD, Hinder LM, Feldman EL.

Lancet Neurol. 2017 Oct;16(10):774. doi: 10.1016/S1474-4422(17)30293-4. Epub 2017 Sep 12. No abstract available.

PMID:
28920882
35.

Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin.

Pustovit RV, Callaghan B, Ringuet MT, Kerr NF, Hunne B, Smyth IM, Pietra C, Furness JB.

Physiol Rep. 2017 Aug;5(15). pii: e13385. doi: 10.14814/phy2.13385.

36.

Dizziness Symptom Type Prevalence and Overlap: A US Nationally Representative Survey.

Kerber KA, Callaghan BC, Telian SA, Meurer WJ, Skolarus LE, Carender W, Burke JF.

Am J Med. 2017 Dec;130(12):1465.e1-1465.e9. doi: 10.1016/j.amjmed.2017.05.048. Epub 2017 Jul 21.

PMID:
28739195
37.

Electrodiagnostic tests are unlikely to change management in those with a known cause of typical distal symmetric polyneuropathy.

Callaghan BC, Burke JF, Kerber KA, Albers JW, Feldman EL.

Muscle Nerve. 2017 Sep;56(3):E25. doi: 10.1002/mus.25713. Epub 2017 Jun 22. No abstract available.

38.

Neurological consequences of obesity.

O'Brien PD, Hinder LM, Callaghan BC, Feldman EL.

Lancet Neurol. 2017 Jun;16(6):465-477. doi: 10.1016/S1474-4422(17)30084-4. Review.

39.

Heterogeneity of enterochromaffin cells within the gastrointestinal tract.

Diwakarla S, Fothergill LJ, Fakhry J, Callaghan B, Furness JB.

Neurogastroenterol Motil. 2017 Jun;29(6). doi: 10.1111/nmo.13101. Review.

40.

Costorage of Enteroendocrine Hormones Evaluated at the Cell and Subcellular Levels in Male Mice.

Fothergill LJ, Callaghan B, Hunne B, Bravo DM, Furness JB.

Endocrinology. 2017 Jul 1;158(7):2113-2123. doi: 10.1210/en.2017-00243.

PMID:
28430903
41.

Distribution and characterisation of CCK containing enteroendocrine cells of the mouse small and large intestine.

Fakhry J, Wang J, Martins P, Fothergill LJ, Hunne B, Prieur P, Shulkes A, Rehfeld JF, Callaghan B, Furness JB.

Cell Tissue Res. 2017 Aug;369(2):245-253. doi: 10.1007/s00441-017-2612-1. Epub 2017 Apr 17.

PMID:
28413860
42.

Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes.

Ang L, Jaiswal M, Callaghan B, Raffel D, B Brown M, Pop-Busui R.

Auton Neurosci. 2017 Jul;205:87-92. doi: 10.1016/j.autneu.2017.03.001. Epub 2017 Mar 10.

43.

Adjuvant Antibiotic Activity of Acidic Sophorolipids with Potential for Facilitating Wound Healing.

Lydon HL, Baccile N, Callaghan B, Marchant R, Mitchell CA, Banat IM.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02547-16. doi: 10.1128/AAC.02547-16. Print 2017 May.

44.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):608. doi: 10.1212/WNL.0000000000003594. No abstract available.

PMID:
28167625
45.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):607-608. doi: 10.1212/WNL.0000000000003581. No abstract available.

PMID:
28167623
46.

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Grisold A, Callaghan BC, Feldman EL.

Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):103-111. doi: 10.1097/MED.0000000000000320. Review.

47.

Ghrelin and Motilin Control Systems in GI Physiology and Therapeutics.

Sanger GJ, Broad J, Callaghan B, Furness JB.

Handb Exp Pharmacol. 2017;239:379-416. doi: 10.1007/164_2016_104. Review.

PMID:
28035532
48.

Overcoming barriers to diabetic polyneuropathy management in primary care.

Adams AS, Callaghan B, Grant RW.

Healthc (Amst). 2017 Dec;5(4):171-173. doi: 10.1016/j.hjdsi.2016.10.003. Epub 2016 Dec 7.

PMID:
27939169
49.

Analysis of enteroendocrine cell populations in the human colon.

Martins P, Fakhry J, de Oliveira EC, Hunne B, Fothergill LJ, Ringuet M, Reis DD, Rehfeld JF, Callaghan B, Furness JB.

Cell Tissue Res. 2017 Feb;367(2):161-168. doi: 10.1007/s00441-016-2530-7. Epub 2016 Nov 14.

PMID:
27844204
50.

Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.

Callaghan BC, Xia R, Reynolds E, Banerjee M, Rothberg AE, Burant CF, Villegas-Umana E, Pop-Busui R, Feldman EL.

JAMA Neurol. 2016 Dec 1;73(12):1468-1476. doi: 10.1001/jamaneurol.2016.3745.

Supplemental Content

Loading ...
Support Center